Biosenta Statistics
Total Valuation
Biosenta has a market cap or net worth of CAD 4.92 million. The enterprise value is 10.81 million.
Market Cap | 4.92M |
Enterprise Value | 10.81M |
Important Dates
The last earnings date was Wednesday, March 5, 2025.
Earnings Date | Mar 5, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
Biosenta has 32.83 million shares outstanding. The number of shares has increased by 14.98% in one year.
Current Share Class | n/a |
Shares Outstanding | 32.83M |
Shares Change (YoY) | +14.98% |
Shares Change (QoQ) | +1.77% |
Owned by Insiders (%) | 29.05% |
Owned by Institutions (%) | 6.66% |
Float | 17.02M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
PB Ratio | n/a |
P/TBV Ratio | n/a |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | -4.61 |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | -16.91 |
Financial Position
The company has a current ratio of 0.05
Current Ratio | 0.05 |
Quick Ratio | 0.03 |
Debt / Equity | n/a |
Debt / EBITDA | n/a |
Debt / FCF | -9.28 |
Interest Coverage | -0.91 |
Financial Efficiency
Return on Equity (ROE) | n/a |
Return on Assets (ROA) | -321.17% |
Return on Invested Capital (ROIC) | n/a |
Return on Capital Employed (ROCE) | 39.65% |
Revenue Per Employee | n/a |
Profits Per Employee | n/a |
Employee Count | n/a |
Asset Turnover | 0.01 |
Inventory Turnover | 0.02 |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -69.39% in the last 52 weeks. The beta is 0.02, so Biosenta's price volatility has been lower than the market average.
Beta (5Y) | 0.02 |
52-Week Price Change | -69.39% |
50-Day Moving Average | 0.15 |
200-Day Moving Average | 0.19 |
Relative Strength Index (RSI) | 45.51 |
Average Volume (20 Days) | 988 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Biosenta had revenue of CAD 1,669 and -2.34 million in losses. Loss per share was -0.08.
Revenue | 1,669 |
Gross Profit | 1,029 |
Operating Income | -1.11M |
Pretax Income | -2.34M |
Net Income | -2.34M |
EBITDA | n/a |
EBIT | -1.11M |
Loss Per Share | -0.08 |
Balance Sheet
The company has 45,494 in cash and 5.93 million in debt, giving a net cash position of -5.89 million or -0.18 per share.
Cash & Cash Equivalents | 45,494 |
Total Debt | 5.93M |
Net Cash | -5.89M |
Net Cash Per Share | -0.18 |
Equity (Book Value) | -8.39M |
Book Value Per Share | -0.26 |
Working Capital | -2.84M |
Cash Flow
In the last 12 months, operating cash flow was -613,559 and capital expenditures -25,861, giving a free cash flow of -639,420.
Operating Cash Flow | -613,559 |
Capital Expenditures | -25,861 |
Free Cash Flow | -639,420 |
FCF Per Share | -0.02 |
Margins
Gross Margin | 61.65% |
Operating Margin | -66,561.05% |
Pretax Margin | -140,445.24% |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
Biosenta does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -14.98% |
Shareholder Yield | -14.98% |
Earnings Yield | -47.60% |
FCF Yield | -12.99% |
Stock Splits
The last stock split was on June 28, 2016. It was a reverse split with a ratio of 0.0666666666.
Last Split Date | Jun 28, 2016 |
Split Type | Reverse |
Split Ratio | 0.0666666666 |
Scores
Biosenta has an Altman Z-Score of -233.06. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | -233.06 |
Piotroski F-Score | n/a |